Empresa Kinder Holding Corp OTC Bulletin Board
Acciones
US4945261067
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 75 | 01/02/14 | |
Evan Wasoff
DFI | Director of Finance/CFO | 77 | - |
Jeremy Reeh
CTO | Chief Tech/Sci/R&D Officer | - | 26/10/18 |
Robert Goldfarb
COO | Chief Operating Officer | 69 | - |
Frank Manganella
PRN | Corporate Officer/Principal | 58 | 30/10/18 |
Joseph Aceto
PRN | Corporate Officer/Principal | 66 | 30/10/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lindy Snider
BRD | Director/Board Member | 64 | 26/01/18 |
Chief Executive Officer | 75 | 01/02/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 67 472 196 | 30 966 703 ( 45,90 %) | 0 | 45,90 % |
Información de la empresa
Nexien BioPharma, Inc.
4340 East Kentucky Avenue Suite 206
80246, Glendale
+303 495 7583
http://www.nexienbiopharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+32,09 % | 694 mil M | |
+29,39 % | 593 mil M | |
-1,34 % | 371 mil M | |
+20,34 % | 331 mil M | |
+7,39 % | 290 mil M | |
+14,25 % | 239 mil M | |
-3,03 % | 209 mil M | |
+10,02 % | 209 mil M | |
+8,49 % | 169 mil M |